Magnus Essand

5.7k citations
124 papers · 4.1k indexed · h-index 34
Topics
Virus-based gene therapy research (48 papers)CAR-T cell therapy research (40 papers)Immunotherapy and Immune Responses (33 papers)

In The Last Decade

Magnus Essand

122 papers receiving 4.0k citations

Peers

Magnus Essand
Comparison fields: 5 of 107
  • Oncology 1.9k
  • Molecular Biology 1.6k
  • Immunology 1.4k
  • Genetics 1.1k
  • Biomedical Engineering 351
Replace Angelica Loskog with:
Angelica Loskog Sweden
Paolo Vezzoni Italy
Katharine A. Whartenby United States
Luis Álvarez‐Vallina Spain
Marta M. Alonso Spain
Satoru Senju Japan
Alessandra Eva Italy
Kurt M. Kroeger United States
Carl W. Rettenmier United States
C. Ryan Miller United States
Magnus Essand relative to Angelica Loskog Sweden Angelica Loskog's profile →
Citations per field
00.5×1.5×
Angelica Loskog · 1×
Citations per year

Countries citing papers authored by Magnus Essand

Since Specialization
Citations

This map shows the geographic impact of Magnus Essand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Essand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Essand more than expected).

Fields of papers citing papers by Magnus Essand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Essand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Essand. The network helps show where Magnus Essand may publish in the future.

Co-authorship network of co-authors of Magnus Essand

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Essand. A scholar is included among the top collaborators of Magnus Essand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Essand. Magnus Essand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 5
4 8
5 28
6 3
7 11
8 20
9 107
10 18
11 18
12 207
13 21
14
CAR T-Cells with Induced Secretion of Helicobacter Pylori Neutrophil-Activating Protein (HP-NAP) Yields Improved Anti-Tumor Activity and Reduced Immunosuppression
1
15 44
16 52
17 59
18 86
19 101
20 64

About Magnus Essand

Magnus Essand is a scholar working on Immunology, Oncology and Genetics, having authored 124 papers that have together received 4.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (48 papers), CAR-T cell therapy research (40 papers) and Immunotherapy and Immune Responses (33 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (1.4k citations) and Genetics (1.1k citations). Magnus Essand has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Di Yu, Mohanraj Ramachandran, Angelica Loskog, Thomas H. Tötterman, Ira Pastan, Miika Martikainen, Byung Kook Lee, George Vasmatzis, Berith Nilsson and Anna Dimberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026